What is Happening
In the often-unpredictable world of **biotechnology stocks**, one name frequently captures attention: **Moderna (NASDAQ:MRNA)**. Recently, shares of the pioneering mRNA company experienced a notable dip, falling by 6.5%. This movement naturally prompts questions among investors: what caused the decline, and what does it signal for the company’s future? Despite this recent downturn, MRNA continues to feature prominently on various stock watchlists, notably being highlighted as one of the